Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: kendall harmon who wrote (278)	8/30/1999 7:50:00 PM
From: Vector1	Read Replies (1) \| Respond to of 666

Kendall, Thanks for the response to HTM. Great day for CLTR shorts. Longs will live to fight another day. V1

To: kendall harmon who wrote (278)	8/30/1999 8:14:00 PM
From: Ben Wa	Respond to of 666

Like I said, I know nothing, I'm just confused.

To: kendall harmon who wrote (278)	8/30/1999 10:05:00 PM
From: synchro	Respond to of 666

That quote from the Coulter officer is meaningless. The things he mentioned are what is done DURING the six-month review process, not BEFORE. At this stage the FDA is kicking the BLA back because it did not meet the submission requirements (whatever that may be). This is another case in the lesson of dealing with an intractable bureaucracy: "Do as they say, not what you THINK they say." Who knows, maybe the FDA officials simply have too many pearls up their rear end. But common sense should tell you this: if this is simply a reformatting of data, why would it take until mid-October to complete a re-file? There is something more to it than the official spin. PS: I am not short the stock.